Status:
WITHDRAWN
Medical Versus Surgical Management of Moderate Mitral Regurgitation Following Percutaneous Coronary Intervention
Lead Sponsor:
Southern Illinois University
Conditions:
Myocardial Infarction
Mitral Regurgitation
Eligibility:
All Genders
19-75 years
Phase:
PHASE1
PHASE2
Brief Summary
The pilot prospective randomized trial is designed to determine the safety and feasibility of enrolling patients to surgically correct residual Mitral Regurgitation (MR) following Percutaneous Coronar...
Detailed Description
Mitral regurgitation (MR) is a frequent complication of myocardial infarction. Ischemic MR portends a poor prognosis on long term follow up. This pilot prospective randomized trial is a safety and fea...
Eligibility Criteria
Inclusion
- Patients who have undergone PCI for first acute MI (index MI) since 7/1/09 at MMC and STJ
- documented moderate mitral regurgitation on follow up echocardiography six or more weeks after PCI procedure
- English speaking
Exclusion
- CABG after PCI for acute MI
- History of previous MI prior to index MI
- History of previous PCI or CABG prior to index PCI
- EF \<30 % on the echocardiogram at 6 weeks after PCI for MI
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01156441
Start Date
July 1 2010
End Date
June 1 2014
Last Update
June 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southern Illinois University School of Medicine
Springfield, Illinois, United States, 62794-9638